Compounds are provided that act as potent antagonists of chemokine receptors . The compounds are generally aryl sulfonamide derivatives and are useful in pharmaceutical compositions, methods for the treatment of chemokine receptor - mediated diseases, and as controls in assays for the identification of chemokine antagonists.
